Meba Banla Selected Research

Necatoriasis

1/2006

Cytokine and chemokine responses in patients co-infected with Entamoeba histolytica/dispar, Necator americanus and Mansonella perstans and changes after anti-parasite treatment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Meba Banla Research Topics

Disease

7	Infections 01/2016 - 04/2004
6	Parasitic Diseases (Parasitic Disease) 01/2022 - 06/2003
3	Intestinal Volvulus (Volvulus) 01/2022 - 06/2003
2	Onchocerciasis 01/2022 - 05/2012
1	Inflammation (Inflammations) 01/2016
1	Reinfection 05/2012
1	Coinfection 06/2009
1	Dracunculiasis 03/2008
1	Necatoriasis 01/2006
1	Filariasis 01/2006
1	Amebiasis (Amoebiasis) 01/2006
1	Entamoebiasis 06/2003

Drug/Important Bio-Agent (IBA)

9	CytokinesIBA 01/2022 - 06/2003
7	ChemokinesIBA 01/2022 - 01/2006
6	AntigensIBA 01/2022 - 06/2003
2	Immunoglobulin G (IgG)IBA 01/2022 - 06/2010
2	Ivermectin (Mectizan)FDA Link 01/2022 - 05/2012
2	Immunoglobulins (Immunoglobulin)IBA 01/2016 - 06/2010
2	Interleukin-12 (IL 12)IBA 03/2008 - 06/2003
1	VaccinesIBA 01/2022
1	MitogensIBA 01/2022
1	Helminth AntigensIBA 01/2016
1	AllergensIBA 01/2016
1	Interleukin-13IBA 05/2012
1	Interleukin-10 (Interleukin 10)IBA 03/2008
1	Interleukin-5 (Interleukin 5)IBA 03/2008
1	Chemokine CCL17IBA 01/2006
1	Chemokine CCL22IBA 01/2006
1	Chemokine CCL4IBA 01/2006
1	Interleukin-18 (Interleukin 18)IBA 06/2003
1	InterleukinsIBA 06/2003

Therapy/Procedure

1	Mass Drug Administration 01/2022
1	Aftercare (After-Treatment) 06/2009
1	Therapeutics 01/2006